Flagship · Bulletin

Macro rationale

Neutral, unchanged. This is an event-driven pillar_floor patch, not a regime re-read. Macro digest holds neutral: HY OAS 2.67 (near historic tights) and VIX 16 flag complacency, not distress; QQQ +11.73% above 200d keeps the extension escalator active (ceiling 25%). The AI-capex/memory flow is structurally intact — MU's FQ3 blowout + 16 SCAs (~$100B contracted through 2030) confirm compute drift is discount-rate, not demand. Cash carried at 19.67% is above the NEUTRAL base band (5-15%); the floor-restore lets me bring it back toward base as a named use of proceeds while still holding a cushion against a credit-spread reversion.

Thesis

Event-driven pillar_floor patch, scope-locked to [ANET,AVGO,LLY,MU,TSM,NVDA,ASML,FN]. The gate is a binding §2/§3 breach: biology fell to 1.03% (LLY only) after last run trimmed LLY under a "biology-underweight" directive that actually broke the 10% floor. Of the eight in-scope tickers only LLY is biology, so the floor is restored through LLY — added to 10.5%, funded entirely from the above-base cash sleeve (19.67% → 10.20%, back inside the NEUTRAL band) rather than by trimming intact compute franchises. LLY is a genuinely durable compounder (GLP-1 leadership, oral orforglipron now approved, 82.9% margin, fcf+, GPFG holder), so this is a sanctioned diversification-floor restore, not rotation-chasing. Every other position holds verbatim at delta 0 per the scope lock and my unchanged read: compute score drift is Warsh-Fed discount-rate compression, not a demand break — MU's ~$100B SCA book keeps confirming the AI-capex flow is structurally intact. No opens (stale_policy + scope), so the book stays at 16 vs the 18-20 band — a structural gap that must close at the next full deep run.

Reflection

Not a flow shift — a mechanical pillar-floor correction. Biology breached the binding 10% floor after LLY was over-trimmed; restoring via LLY (only in-scope bio name), funded from above-base cash.

Recurring self-inflicted problem: last run I trimmed LLY to 1.03% citing a 'biology-underweight directive,' which is exactly what the binding §2/§3 floor exists to catch — a strategic-weight instruction quietly took a whole pillar below its mandatory floor. This patch fixes it, but the pattern (letting narrative directives override a hard cap) is worth flagging. Separately, the book is stuck at 16 vs the 18-20 band, and every event-driven scope-lock forbids the open that would fix it — that gap has to close at the next full deep run, likely by adding a second durable biology name (CRSP, VRTX r

Positions (16)

• MUMicron Technologycompute

  hold4.30%79
  flow acceleratingconf

  Funder

  US HBM3E/HBM4 supplier in a capacity-disciplined memory cycle; blowout FQ3 ($41.5B rev +17%, op income +22%), 16 Strategic Customer Agreements covering ~20% DRAM / ~1/3 NAND through 2030 (~$100B contracted), $27B capex increase; rides ~$725-750B 2026 hyperscaler AI capex. 84.6% margin, fcf+.

  Unwind

  DRAM/NAND spot-price collapse or HBM oversupply breaking the shortage thesis; hyperscaler capex cut; SCA book erosion.

  Catalyst

  FQ4 print vs ~$50B guide; HBM4 qualification cadence

• TSMTaiwan Semiconductor Manufacturingcompute

  hold8.07%83
  flow steadyconf

  Funder

  Leading-edge foundry monopoly (<3nm), >50% gross margin, prodigious FCF, disciplined capex — routes the world's AI silicon. Goldman $920B-$1.4T 2027 AI-capex names TSMC explicitly; CHIPS $6.6B Arizona; Tepper/Appaloosa holds.

  Unwind

  Competitor 3nm yield convergence; gross margin compression below 50%; a genuine AI-capex cut (not KOSPI-margin liquidation noise).

  Catalyst

  July Q2 earnings — the key chip read this cycle

• NVDANVIDIAcompute

  hold3.52%72
  flow softeningconf

  Funder

  CUDA/accelerator software moat, ~75% gross margin, fortress balance sheet. ~$725B 2026 hyperscaler capex anchored on Blackwell/Rubin (MSFT $190B, AMZN $200B, GOOGL $180-190B, META $125-145B); Stargate $500B JV.

  Unwind

  Hyperscaler ASIC displacement of merchant GPU; gross margin break below ~70%; a hyperscaler capex guide-down. Score at 72, held above hard-exit; no add until >80.

  Catalyst

  Q3 data-center revenue + gross-margin guidance

• ASMLASML Holdingcompute

  hold3.83%64
  flow steadyconf

  Funder

  EUV lithography monopoly — the single most irreplaceable tool in advanced semis, ~50% gross margin, multi-year backlog, no commercial-scale alternative. Norway GPFG holds; Coatue/Third Point added Q1; TSMC/Samsung/Intel EUV orderbook; Intel sole High-NA EXE:5200B HVM buyer.

  Unwind

  Book-to-bill breaks below threshold at Q2 results; a commercial EUV alternative; large order cancellations. Score 64 — trim discipline engages only below 60.

  Catalyst

  July 15 Q2 earnings — bookings/book-to-bill

• AVGOBroadcomcompute

  hold2.74%62
  flow steadyconf

  Funder

  Custom-silicon ASIC leader (~70% share) + VMware software, huge FCF, $7B+ buyback, serial dividend grower. GOOG TPU multi-gen, META MTIA, Anthropic 3.5GW ASIC contracts; Apple 10-yr partnership through 2031; Q2 AI segment +143% to $10.8B.

  Unwind

  ASIC share loss; AI-segment bookings disappoint next print; FCF/buyback break. Score 62, 2pts above broken threshold — hard review if <60.

  Catalyst

  Next quarterly AI-segment bookings update

• ANETArista Networkscompute

  hold2.35%67
  flow steadyconf

  Funder

  Durable hyperscaler-networking franchise, share-gainer since 2004, ~65% gross margin, net cash, single-image EOS software moat, Ullal-led capital discipline. Microsoft & Meta named largest customers funding 35% YoY revenue; MS PT raised to $190.

  Unwind

  NVDA Spectrum-X displacing Arista in a major footprint; forward P/E >45x with growth decel; hyperscaler in-house switching pivot.

  Catalyst

  Q2 earnings — sequential growth vs 8.9% prior quarter

• FNcompute

  hold1.66%63
  flow softeningconf

  Funder

  Optical transceiver/packaging manufacturer interconnecting hyperscaler AI clusters; capital-light, debt-free, extracts hyperscaler capex without silicon R&D risk. AWS dominant customer drove ~36% YoY growth; 800G/1.6T demand; record $1.2B quarterly rev.

  Unwind

  P/E >35x during decelerating growth; Datacom sequential-growth break; gross-margin compression. Second-hyperscaler 800G design-win still unverified.

  Catalyst

  Next-quarter Datacom growth guidance

• CCJCamecoenergy

  hold8.13%65
  flow steadyconf

  Funder

  Tail-risk hedge slot: tier-1 Saskatchewan uranium franchise + Westinghouse 49% JV with Brookfield. DOE $17.5B AP1000 loan commitment, Kazatomprom 8Mlb output cut sustaining a structural deficit, contract book $60+/lb vs ~$94 term; AI-driven nuclear demand.

  Unwind

  Uranium spot/term price collapse; contract-book erosion; DOE loan program withdrawal. Score drift (65) alone is not a trim trigger — thematic tailwind intact.

  Catalyst

  Next contracting update / DOE AP1000 loan disbursement

• GEVGE Vernovaenergy

  hold7.51%63
  flow acceleratingconf

  Funder

  Gas-turbine + grid franchise with pricing power — ~$163B backlog (to ~$200B by 2027), 100GW turbine backlog, 10-20% price realization. Norway GPFG added post-spin; Oracle $90-95B FY27 + Alphabet $80B capex pull-through; +21% June on hyperscaler capex.

  Unwind

  Backlog cancellation or wind-loss deterioration; EV/EBITDA breaching ~25x exit ceiling; a hyperscaler power-capex cut.

  Catalyst

  Q2 earnings + backlog update toward $200B

• SCCOSouthern Copperenergy

  hold7.53%63
  flow steadyconf

  Funder

  Tail-risk hedge slot: lowest-cost copper producer, vast reserves, fat margins, large dividend. Copper supply deficit ~320k tonnes 2026, record Q1 NI $1.58B, AI/data-center ~30% of new copper demand by 2030 (BloombergNEF); Mexican-gov owner.

  Unwind

  Copper price collapse below entry thesis; Peru/Mexico permitting shock; AI/grid demand thesis break.

  Catalyst

  Q2 earnings / copper spot vs supply-deficit thesis

• MPMP Materialsenergy

  hold4.48%
  flow reversingconf

  Funder

  Only scaled US rare-earth + magnet producer; DoD $400M Series A preferred + $150M loan + 10-yr $110/kg NdPr price floor + 10-yr magnet offtake for the 10X facility — a government-backstopped moat vs China's ~98% magnet control.

  Unwind

  FCF stays negative through the magnet ramp; China blacklist chokes processing-tech access materially; 10X facility construction slips; DoD backstop withdrawn.

  Catalyst

  Blacklist operational-impact clarity + TTM FCF-positive print; 10X facility milestones

• NEMNewmont Corporationenergy

  hold5.43%89
  flow softeningconf

  Funder

  Tail-risk equity hedge (§5.3/10.2): largest gold producer, tier-1 long-life assets, strong post-Newcrest FCF and dividend, improving cost discipline. Red Chris JV secured $500M Canadian-government backing; central-bank gold accumulation as a frozen-Fed stagflation hedge.

  Unwind

  Gold sustained bear market driven by rising real yields (Fed-credibility repricing, not stagflation) evaporating the tail bid; cost inflation; FCF break. Lock until 2026-07-15.

  Catalyst

  Q2 earnings; gold price vs bear-market threshold

• KTOSKratos Defensedefense

  hold9.25%
  flow steadyconf

  Funder

  Tactical drones (XQ-58 Valkyrie), hypersonics, turbine engines — DAWG-adjacent defense-tech. DoD MACH-TB 2.0 $1.45B IDIQ, Project Helios $68.3M, USMC Valkyrie mods; FY27 DAWG ~$54.6B line; UK £5B drone investment; ARK accumulation.

  Unwind

  FY27 DAWG appropriations cut; revenue-inflection/margin-firming fails to confirm; quarterly contract flow stalls. Held at delta 0 per scope lock.

  Catalyst

  FY27 DAWG appropriations markup / quarterly contract flow

• HEIHEICOdefense

  hold10.11%68
  flow steadyconf

  Funder

  Defense/aero aftermarket compounder — Mendelson family owners since 1957, 20%+ FCF CAGR, disciplined serial acquirer ($1B+/yr). Q2 beat (FSG $929M vs $864M, ETG $460M vs $396M); NDAA mandatory funding + commercial-aerospace MRO. Buffett holding.

  Unwind

  Forward P/E >50x without accelerating growth; organic growth below the ~6% floor; a value-destroying acquisition or capital-allocation break.

  Catalyst

  Next quarterly print — FSG/ETG organic growth vs the ~54x multiple

• PSNdefense

  hold2.91%50
  flow softeningconf

  Funder

  C5ISR/cyber government-services prime, sticky multi-year IDIQ backlog: MDA SHIELD $151B-ceiling IDIQ, DTRA cyber $137M, USAF MATOC $15B, Navy WEXMAC $10B, plus the $1.1-1.4B Blatnik Bridge win and Lusail program.

  Unwind

  Score already 50 (below 60 floor); SHIELD task-order conversion continues to fail; book-to-bill deteriorates further. Weakening — flagged for review but held at delta 0 per this run's scope lock.

  Catalyst

  SHIELD task-order conversion / book-to-bill next print

• LLYEli Lillybiology

  hold10.00%70
  flow steadyconf

  Funder

  Premier pharma compounder — Mounjaro/Zepbound GLP-1 franchise (~60% US GLP-1 share, $12B+ quarterly sales) + oral orforglipron (Foundayo) FDA-approved Apr 2026 + retatrutide Ph3 (~70lb loss) extending a multi-decade runway; 82.9% margin, fcf+, strong capital return; $27B manufacturing expansion. Norway GPFG + large AM holders. RESTORING to the binding §2/§3 10% biology pillar floor after last run'

  Unwind

  10pt US GLP-1 share loss to NVO; retatrutide Ph3 failure; margin/FCF deterioration; a CMS Part-D/IRA pricing shock. Not rate-vise cash-burn biotech — profitable and self-funding.

  Catalyst

  Retatrutide Ph3 readouts / GLP-1 script-share data; oral Foundayo launch trajectory

Warnings

• stale_policy guard: LLY add → hold (delta zeroed)
• §2 cap re-applied after pillar tilt: MU
• §2 cap re-applied after pillar tilt: NVDA
• §2 cap re-applied after pillar tilt: AVGO
• §2 cap re-applied after pillar tilt: ANET
• §2 cap re-applied after pillar tilt: FN
• §2 cap re-applied after pillar tilt: GEV
• §2 cap re-applied after pillar tilt: MP
• §2 cap re-applied after pillar tilt: NEM
• §2 cap re-applied after pillar tilt: KTOS
• §2 cap re-applied after pillar tilt: HEI
• §2 cap re-applied after pillar tilt: PSN
• §2 cap re-applied after pillar tilt: LLY
• position_count: 16 < 18 after mechanical closes (§2 floor) — book under-populated; strategist must open replacements next run
• hedge_floor: only 2/3 tail-risk names held (floor escalated: AI-load 42.1% > 40%) — open a gold/oil/diversified-commodity hedge (§5.3); uranium & power-gen do not count
• ledger stale (ledger over-bought (cash -36.14% of NAV)) — rebalance diffed against intent

Conviction-lock actions

1. Turn 1ConvictionGuard (§6.5d)

   —

Cost breakdown

Per-call cost computed from cost.js pricing constants (Opus 4.7, Sonnet 4.6, Haiku 4.5). Cache-read tokens billed at 10% of input. See Cost & ROI for the rolling 30-day ledger.